lifestyle.brightsfuture.com

Author: Black Diamond Group Limited

Arvinas Announces FDA Approval of VEPPANU (vepdegestrant) for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer

May 3, 2026
Black Diamond Reports First Quarter Results and Declares Dividend

April 30, 2026
Black Diamond Group Announces Expansion Of Asset-Based Credit Facility

April 27, 2026
Black Diamond Reports Strong Fourth Quarter and Year-End Results and Declares Dividend

March 12, 2026
Black Diamond Group Limited Announces Timing of Fourth Quarter and Year-End 2025 Financial Results and Conference Call

March 9, 2026